MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS), today announced the appointment of Veronica Gambillara Fonck ...

With the Covid-19 epidemic in Denmark under control and other vaccines available, it was decided to discontinue the use of the AZ product. Argentina has deepened Wednesday its restrictive measures ...

New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results ...

Hexavalent, six-in-one vaccine can reduce spread of the disease and cut costs ANALYSIS | ESTHER NAKKAZI | Pertussis, or ...

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

(Reuters) - An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the ...

Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment ...

COPENHAGEN, Denmark, October 31, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in ...

Howard Lutnick has suggested Robert F. Kennedy Jr., a notorious anti-vaccine activist, may be granted access to federal ...

Hørsholm, Denmark, 14 November 2024 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its third quarter and year-to-date financial results for 2024. The report is available as an attachme ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...